VERU has been mentioned a few times... YEAR END
Post# of 1418
(Total Views: 233)
Posted On: 07/03/2022 9:32:08 PM
VERU has been mentioned a few times...
YEAR ENDED SEPTEMBER 30, 2021 COMPARED TO YEAR ENDED SEPTEMBER 30, 2020
The Company generated net revenues of $61.3 million and net income of $7.4 million, or $0.10 per basic common
share and $0.09 per diluted common share, in fiscal 2021, compared to net revenues of $42.6 million and net loss of
$19.0 m
Oh how fast things can change
Market Cap at $896M is x15 revenue
Todos
Total revenue for the full year 2021 was $12.28 million versus revenues of $5.21 million in 2020
I love companies that double their revenue each year. Not many do. Actually, many have zero revenue.
Market cap @ $15.51M is slightly above revenue
If you used a forward looking multiple of x15 of revenue, that would be a market cap of $185M
Roughly a $.20 share price
What if Todos doubles revenues like they hope to this year?
That would be a market cap at x15 revenues of $375M
This doesn't factor in the spinoff, Videssa, etc. Just near term potential.
I'm looking forward to hearing about the EU deal being finalized. Maybe that could fund some or most of 3CL
YEAR ENDED SEPTEMBER 30, 2021 COMPARED TO YEAR ENDED SEPTEMBER 30, 2020
The Company generated net revenues of $61.3 million and net income of $7.4 million, or $0.10 per basic common
share and $0.09 per diluted common share, in fiscal 2021, compared to net revenues of $42.6 million and net loss of
$19.0 m
Oh how fast things can change
Market Cap at $896M is x15 revenue
Todos
Total revenue for the full year 2021 was $12.28 million versus revenues of $5.21 million in 2020
I love companies that double their revenue each year. Not many do. Actually, many have zero revenue.
Market cap @ $15.51M is slightly above revenue
If you used a forward looking multiple of x15 of revenue, that would be a market cap of $185M
Roughly a $.20 share price
What if Todos doubles revenues like they hope to this year?
That would be a market cap at x15 revenues of $375M
This doesn't factor in the spinoff, Videssa, etc. Just near term potential.
I'm looking forward to hearing about the EU deal being finalized. Maybe that could fund some or most of 3CL
(0)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼